Guideng Li

3.0k citations
43 papers · 1.8k indexed · h-index 21
Topics
Immune Cell Function and Interaction (13 papers)T-cell and B-cell Immunology (9 papers)CAR-T cell therapy research (7 papers)

In The Last Decade

Guideng Li

41 papers receiving 1.8k citations

Peers

Guideng Li
Comparison fields: 5 of 110
  • Molecular Biology 947
  • Immunology 841
  • Oncology 482
  • Cancer Research 305
  • Radiology, Nuclear Medicine and Imaging 137
Replace Tony Avril with:
Tony Avril France
Victoria C. Pham United States
Eiji Kobayashi Japan
Barbara Molon Italy
Gwenola Manic Italy
Anan Chuntharapai United States
Jenny Jongstra‐Bilen Canada
Salvatore J. Coniglio United States
Bryan C. Barnhart United States
Arabinda Samanta United States
Guideng Li relative to Tony Avril France Tony Avril's profile →
Citations per field
00.5×
Tony Avril · 1×
Citations per year

Countries citing papers authored by Guideng Li

Since Specialization
Citations

This map shows the geographic impact of Guideng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guideng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guideng Li more than expected).

Fields of papers citing papers by Guideng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guideng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guideng Li. The network helps show where Guideng Li may publish in the future.

Co-authorship network of co-authors of Guideng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guideng Li. A scholar is included among the top collaborators of Guideng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guideng Li. Guideng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 4
5 3
6 1
7 2
8 3
9 1
10 30
11 92
12 15
13 96
14 184
15 107
16 65
17 31
18 185
19
Prolyl isomerase Pin1 plays a dual role in cell proliferation and apoptosis by isomerizing orphan receptor TR3
1
20 16

About Guideng Li

Guideng Li is a scholar working on Immunology, Cancer Research and Oncology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (9 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Immunology (841 citations), Cancer Research (305 citations) and Oncology (482 citations). Guideng Li has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include David Baltimore, Luke Frankiw, Alok V. Joglekar, Paolo Casali, Jessica K. Wang, Hong Zan, Zhenming Xu, Zhe Wang, Clayton A. White and Egest J. Pone. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026